Literature DB >> 8557343

The Salmonella dublin virulence plasmid does not modulate early T-cell responses in mice.

L A Guilloteau1, A J Lax, S MacIntyre, T S Wallis.   

Abstract

The virulence plasmid in Salmonella dublin mediates systemic infection in mice and cattle. The role of gamma delta T cells or hepatic extrathymic T cells has recently been reported to be important in the control of the early stage of Salmonella choleraesuis infections of mice. Here, we report on T-cell responses in conventional mice after challenge with a virulent strain of S. dublin carrying a virulence plasmid or with a strain cured of the plasmid. Over a period of 4 days postinfection, when both strains could be compared, similar changes in alpha beta and gamma delta T-cell subsets in peritoneal cavities, livers, and spleens were recorded, demonstrating no clear role of the virulence plasmid in modulation of early T-cell responses. To investigate further the role of the virulence plasmid in pathogenesis, the growth of the plasmid-cured strain was assessed in SCID, SCID bg, and irradiated mice. During the first 6 days after infection, there was no statistically difference in the net growth of Salmonella cells in the livers and spleens of SCID and SCID bg mice compared with conventional BALB/mice. This observation excludes a key role for a T- or B-cell-mediated immune response in controlling the initial growth of the plasmid-cured S. dublin strain. Thereafter, the immunocompromised mice were no longer able to control infection, although SCID mice were more efficient at controlling net bacterial multiplication than SCID bg mice, potentially implicating NK cells in the control of infection in SCID mice. The early control of net bacterial multiplication in the spleens and livers of BALB/c mice was ablated by whole-body X-irradiation. Both wild-type and plasmid-cured strains multiplied significantly more rapidly in irradiated than in conventional BALB/c mice. However, the numbers of wild-type bacterial still increased more rapidly than in the numbers of the cured strains. These results are consistent with a role of the S. dublin virulence plasmid in promoting in vivo growth of Salmonella cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8557343      PMCID: PMC173749          DOI: 10.1128/iai.64.1.222-229.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  The beige mutation in the mouse selectively impairs natural killer cell function.

Authors:  J Roder; A Duwe
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

Review 2.  Molecular analysis of spv virulence genes of the Salmonella virulence plasmids.

Authors:  P A Gulig; H Danbara; D G Guiney; A J Lax; F Norel; M Rhen
Journal:  Mol Microbiol       Date:  1993-03       Impact factor: 3.501

3.  Salmonella typhimurium induces IFN-gamma production in murine splenocytes. Role of natural killer cells and macrophages.

Authors:  L Ramarathinam; D W Niesel; G R Klimpel
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

4.  Mouse T lymphocytes that express a gamma delta T-cell antigen receptor contribute to resistance to Salmonella infection in vivo.

Authors:  P F Mixter; V Camerini; B J Stone; V L Miller; M Kronenberg
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

5.  The virulence plasmid does not contribute to growth of Salmonella in cultured murine macrophages.

Authors:  P Riikonen; P H Mäkelä; H Saarilahti; S Sukupolvi; S Taira; M Rhen
Journal:  Microb Pathog       Date:  1992-10       Impact factor: 3.738

6.  The Salmonella typhimurium virulence plasmid increases the growth rate of salmonellae in mice.

Authors:  P A Gulig; T J Doyle
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

7.  Evidence for related virulence sequences in plasmids of Salmonella dublin and Salmonella typhimurium.

Authors:  G D Baird; E J Manning; P W Jones
Journal:  J Gen Microbiol       Date:  1985-07

8.  A protective role of extrathymic alpha beta TcR cells in the liver in primary murine salmonellosis.

Authors:  Y Matsumoto; M Emoto; J Usami; K Maeda; Y Yoshikai
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

9.  Induction of murine peritoneal gamma/delta T cells and their role in resistance to bacterial infection.

Authors:  M J Skeen; H K Ziegler
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

10.  Intercellular interactions and cytokine responsiveness of peritoneal alpha/beta and gamma/delta T cells from Listeria-infected mice: synergistic effects of interleukin 1 and 7 on gamma/delta T cells.

Authors:  M J Skeen; H K Ziegler
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Use of preferentially replicating bacteria for the treatment of cancer.

Authors:  M Sznol; S L Lin; D Bermudes; L M Zheng; I King
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Analysis of host cells associated with the Spv-mediated increased intracellular growth rate of Salmonella typhimurium in mice.

Authors:  P A Gulig; T J Doyle; J A Hughes; H Matsui
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Role of alphabeta and gammadelta T cells in the host response to Salmonella infection as demonstrated in T-cell-receptor-deficient mice of defined Ity genotypes.

Authors:  B C Weintraub; L Eckmann; S Okamoto; M Hense; S M Hedrick; J Fierer
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

4.  The Salmonella virulence plasmid enhances Salmonella-induced lysis of macrophages and influences inflammatory responses.

Authors:  L A Guilloteau; T S Wallis; A V Gautier; S MacIntyre; D J Platt; A J Lax
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

5.  B7-H1 (programmed cell death ligand 1) is required for the development of multifunctional Th1 cells and immunity to primary, but not secondary, Salmonella infection.

Authors:  Seung-Joo Lee; Hope O'Donnell; Stephen J McSorley
Journal:  J Immunol       Date:  2010-07-16       Impact factor: 5.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.